tit_pre14c.htm
INFORMATION
STATEMENT
PURSUANT
TO SECTION 14 (C)
OF
THE
SECURITIES EXCHANGE ACT OF 1934
Check the
appropriate box:
[X] Preliminary
information statement
[ ] Confidential,
for Use of the Commission Only
[ ] Definitive
information statement
TONE
IN TWENTY
(Name of
Company as Specified in its Charter)
Payment
of Filing Fee (Check the appropriate box):
[X] No
fee required.
[ ] Fee
computed on table below per Exchange Act Rules 14c-5(g) and 0-11.
|
(1)
|
Title
of each class of securities to which transaction applies: Not
Applicable.
|
|
(2)
|
Aggregate
number of securities to which transaction applies: Not
Applicable.
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing fee is
calculated and state how it was determined): Not
Applicable.
|
|
(4)
|
Proposed
maximum aggregate value of transaction: Not
Applicable.
|
|
(5)
|
Total
fee paid: Not
Applicable.
|
[ ] Fee
paid previously with preliminary materials.
[ ]
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11
(a) (2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its
filing.
|
(1) Amount
Previously Paid: Not Applicable.
(2) Form,
Schedule or Registration Statement No. : Not Applicable.
(3) Filing
Party: Not Applicable.
(4) Date
Filed: Not Applicable.
TONE
IN TWENTY
3433
Losee Rd., Suite 2
North
Las Vegas, NV 89030
NOTICE
OF STOCKHOLDER ACTION TO BE TAKEN
PURSUANT
TO THE WRITTEN CONSENT OF STOCKHOLDERS
_______________________________________________
WE
ARE NOT ASKING YOU FOR A PROXY
AND
YOU
ARE REQUESTED NOT TO SEND US A PROXY
_______________________________________________
February
__, 2010
Dear
Stockholder:
Tone in Twenty (the “Company”, “we”,
“us”, or “our”) is providing to you the following Information Statement to
notify you that our Board of Directors and the holders of a majority of our
outstanding shares of common stock have executed and delivered a written consent
to effect the following corporate actions subject to the closing of the
transaction with Muscle Pharm LLC discussed below under Recent
Developments:
(1) Amend
our Articles of Incorporation to change our corporate name to “MusclePharm
Corporation.” (the “Name Change”); and
(2) Adopt
our 2010 Stock Incentive Plan (the “2010 Plan”).
Stockholders of record at the close of
business on February __, 2010 (the “Record Date”) are entitled to notice of this
stockholder action by written consent. Stockholders representing a majority of
our issued and outstanding shares of Common Stock have consented in writing to
the actions to be taken. Accordingly, your approval is not required and is not
being sought. Moreover, you will not have dissenters' rights.
Please read this notice carefully. It
describes the Name Change, and the 2010 Plan and contains certain related
information. Additional information about the Company is contained in its
current and periodic reports filed with the United States Securities and
Exchange Commission (the “Commission”). These reports, their accompanying
exhibits and other documents filed with the Commission may be inspected without
charge at the Public Reference Section of the Commission at 100 F Street, N.E.,
Washington, DC 20549. Copies of such material may also be obtained from the
Commission at prescribed rates. The Commission also maintains a Web site that
contains reports, proxy and information statements and other information
regarding public companies that file reports with the Commission. Copies of
these reports may be obtained from the Commission’s EDGAR archives at
http://www.sec.gov/index.htm.
Absent any comments from the Securities
and Exchange Commission regarding this Information Statement, we expect these
corporate actions to become effective on the 20th day after the mailing of this
Information Statement to our stockholders of record (the “Effective
Date”).
The Information Statement is being
provided to you for information purposes only as it relates to our Certificate
of Amendment to the Articles of Incorporation and the 2010 Plan. Your vote is
not required to approve the action. This Information Statement does not relate
to an annual meeting or special meeting in lieu of an annual meeting. You are
not being asked to send a proxy and you are requested not to send
one.
We are first mailing this statement on
February __ 2010. We anticipate that the Certificate of amendment to
the Articles of Incorporation will become effective on or after February __,
2010.
THIS
IS NOT A NOTICE OF A MEETING OF STOCKHOLDERS AND NO STOCKHOLDERS’ MEETING WILL
BE HELD TO CONSIDER ANY MATTER DESCRIBED HEREIN.
Very
truly yours,
__________________________
John Dean
Harper
President
INFORMATION
STATEMENT
PURSUANT
TO SECTION 14 OF THE SECURITIES AND EXCHANGE ACT OF 1934,
AS
AMENDED, AND REGULATION 14C AND SCHEDULE 14C THEREUNDER
This Information Statement is being
mailed to inform the stockholders of action taken without a meeting upon the
written consent of the holders of a majority of the outstanding shares of the
common stock of the Company.
WE
ARE NOT ASKING YOU FOR A PROXY AND
YOU
ARE REQUESTED NOT TO SEND US A PROXY.
GENERAL
This Information Statement has been
filed with the Securities and Exchange Commission (the “Commission”) and is
being furnished to the holders of the outstanding shares of common stock, par
value $.0001 per share (the “Common Stock”), of Tone in Twenty, a Nevada
corporation (the “Company”, “we”, “us”, or “our”). The purpose of this
Information Statement is to provide notice under Nevada law and the rules of the
Commission that a majority of the Company's stockholders have, by written
consent in lieu of a meeting, approved the following corporate
actions:
(1) Amend
our Certificate of Incorporation to change our corporate name to “MusclePharm
Corporation.” ( the “Name Change”); and
(2) Adopt
our 2010 Stock Incentive Plan (the “2010 Plan”).
The Company will pay all costs
associated with the distribution of this Information Statement, including the
costs of printing and mailing.
As the Board of Directors of the
Company (the “Board”) and a majority of the Company's stockholders have already
approved of the Certificate of Amendment to the Articles of Incorporation and
the 2010 Plan by written consent, the Company is not seeking approval for the
Certificate of Amendment to the Articles of Incorporation and the 2010 Plan from
any of the Company's remaining stockholders, and the Company's remaining
stockholders will not be given an opportunity to vote on the Certificate of
Amendment to the Articles of Incorporation or the 2010 Plan. All necessary
corporate approvals have been obtained, and this Information Statement is being
furnished solely for the purpose of providing advance notice to the Company's
stockholders of the 2010 Plan and the Certificate of Amendment to the Articles
of Incorporation effecting the Name Change as required by the Securities
Exchange Act of 1934, as amended (the “Exchange Act”).
EXPECTED
DATE FOR EFFECTING THE NAME CHANGE AND 2010 PLAN
Under Section 14(c) of the Exchange Act
and Rule 14c-2 promulgated thereunder, the Name Change and the 2010 Plan cannot
be effected until 20 days after the date that the Definitive Information
Statement is sent to the Company's stockholders. This Preliminary Information
Statement is being filed with the Securities and Exchange Commission on the date
hereof. A Definitive Information Statement is being mailed on or about February
__, 2010 (the “Mailing Date”) to the stockholders of the Company as of the close
of business on February __, 2010 (the “Record Date”). The Company expects to
effect the filing of the Certificate of Amendment to the Articles of
Incorporation with the Nevada Secretary of State and the adoption of the 2010
Plan approximately 20 days after the Mailing Date and after the closing of the
transaction with Muscle Pharm, LLC.. The effective date of the Certificate of
Amendment to the Articles of Incorporation and the 2010 Plan therefore, is
expected to be on or after February __, 2010.
Recent
Developments
On February 1, 2010, we entered into a
Share Exchange Agreement (the "Exchange Agreement") by and among the Company,
Muscle Pharm LLC (hereinafter referred to as “Muscle Pharm”) and its members, in
which we have agreed to issue an aggregate of 26,000,000 shares of our Common
Stock to the members of Muscle Pharm, in exchange for all of the issued and
outstanding member interests of Muscle Pharm. In addition, to facilitate this
transaction our President has agreed to sell his 366,666 shares to Muscle Pharm
for $25,000 and these shares will be cancelled.
Pursuant to the Exchange Agreement, the
members of Muscle Pharm will acquire a controlling number of shares of the
Company, we will acquire all of the outstanding stock of Muscle Pharm, and
Muscle Pharm will become a wholly owned subsidiary of our Company. Upon
completion of the transaction, we will cease our current business and adopt and
continue implementing Muscle Pharm’s business plan. Upon the closing
of the Exchange Agreement, our sole officer/director will resign and those
persons described in the “New Officers and Directors” section below will be
appointed as officers and directors of the Company. The closing of the Exchange
Agreement is expected to take place on or about February 15, 2010.
The closing of the Exchange Agreement
is not contingent on the two items which are the subject of this Information
Statement; however, if the closing does not take place, we will abandon plans to
change our name and to adopt the 2010 Plan. If the transaction is
closed, we will change our name to MusclePharm Corporation and adopt the 2010
Plan 20 days after the date that this Definitive Information Statement has been
mailed to our stockholders.
The closing of the transaction
contemplated by the Exchange Agreement was subject to a number of conditions
including, without limitation, waiting for 10 days after the filing of the Rule
14f-1 Information Statement with the SEC and mailing it to the shareholders, and
other customary closing conditions.
It is pursuant to the Exchange
Agreement that we agreed to effect the corporate actions discussed
herein.
Name
Change
Our Board of Directors, by written
consent dated as of February 1, 2010, approved changing our corporate name from
“Tone in Twenty” to “MusclePharm Corporation” after the closing of the
transaction with Muscle Pharm, LLC. Management believes that changing
our name to MusclePharm Corporation will more accurately reflect the business
since our business will be the business of Muscle Pharm, LLC.
Upon the later of the closing of the
Exchange Agreement or the expiration of the 10-day period following the filing
of this Information Statement with the SEC and mailing of this Information
Statement to our shareholders, we will file a Certificate of Amendment to the
Articles of Incorporation with the Secretary of State of the State of Nevada to
effect the Name Change, to be effective on the Effective Date. Once
we complete the name change, we will need to apply for a new Over-the-Counter
Bulletin Board trading symbol and CUSIP number. We will report our
new symbol and CUSIP number in a Current Report on Form 8-K once it is
established.
2010
Plan
In anticipation of closing the Exchange
Agreement, the Company’s Board of Directors, on February 1, 2010 approved the
establishment of a Stock Incentive Plan (the “2010 Plan” or the “Plan”) subject
to approval of the Company’s shareholders. The following is a summary
of the 2010 Plan. This summary is qualified in its entirely by
reference to the complete text of the 2010 Plan set forth in Exhibit A, annexed
hereto.
Description
of the Plan
The Board of Directors believes that
the 2010 Plan will advance the interests of the Company by encouraging and
providing for the acquisition of an equity interest in the Company by employees,
officers, directors, consultants, advisors, and service providers who provide
services to the Company, and by providing additional incentives and motivation
toward superior Company performance. The Board believes it also will enable the
Company to attract and retain the services of key employees, officers,
directors, consultants, and service providers by providing additional incentives
and motivation toward superior Company performance.
General
The total number of shares that may be
issued pursuant to Stock Incentives under this Plan shall not exceed Five
Million (5,000,000), subject to adjustment in the event of certain
recapitalizations, reorganizations and similar transactions.
The 2010 Plan will be administered by
the Compensation Committee which will be set up after the closing of the
Exchange Agreement. The Compensation Committee has full and exclusive power
within the limitations set forth in the Plan to make all decisions and
determinations regarding the selection of participants and the granting of
awards; establishing the terms and conditions relating to each award; adopting
rules, regulations and guidelines; and interpreting the Plan. The Compensation
Committee will determine the appropriate mix of stock options and stock awards
to be granted to best achieve the objectives of the Plan. The 2010 Plan may be
amended by the Board or the Compensation Committee, without the approval of
stockholders, but no such amendments may increase the number of shares issuable
under the Plan or adversely affect any outstanding awards without the consent of
the holders thereof.
Eligibility
Key employees and directors of the
Company or its subsidiaries and consultants, advisors and service providers who
are eligible to receive shares which are registered on SEC Form S-8 are eligible
to receive awards under the 2010 Plan.
Types of
Awards
The Compensation Committee may
determine the type and terms and conditions of awards under the 2010 Plan.
Awards may be granted in a combination of stock options, stock appreciation
rights, and/or stock awards. Such awards may have terms
providing that the settlement or payment of one type of award automatically
reduces or cancels the remaining award. Awards under the Plan may include the
following:
Stock
Options. Stock options entitle their holders to purchase shares of Common
Stock at a specified price for a specified period. The exercise price of each
option may not be less than 100% of fair market value on the date of grant. Fair
market value for purposes of the 2010 Plan means the mean between the highest
and lowest reported selling prices on a national securities exchange of a share
as reported in the appropriate composite listing for such exchange.
Any stock option granted in the form of
an incentive stock option will be intended to comply with the requirements of
Section 422 of the Internal Revenue Code of 1986, as amended. Only options
granted to employees qualify for incentive stock option treatment. No incentive
stock option shall be granted after February 1, 2020, which is 10 years from the
date the Plan was initially adopted. A stock option may be exercised in whole or
in installments, which may be cumulative. Shares of Common Stock purchased upon
the exercise of a stock option must be paid for in full at the time of the
exercise in cash or such other consideration determined by the Compensation
Committee. Payment may include tendering shares of Common Stock or surrendering
of a stock award, or a combination of methods.
Stock
Appreciation Rights. A stock appreciation right is the right to receive a
payment equal to the excess of the fair market value of a specified number of
shares of Common Stock on the date the stock appreciation right is exercised
over the fair market value on the date of grant of the stock appreciation right.
Any stock appreciation rights granted under the 2010 Plan will require that
payment upon exercise be in the form of Common Stock of the
Company.
Stock
Awards. Stock awards are awards made in Common Stock or denominated in
Common Stock units which entitle the recipient to receive future payments in
either shares, cash, or a combination thereof. Awards may be subject to
conditions established by the Compensation Committee and set forth in the award
agreement, and which may include, but are not limited to, continuous service
with the Company, achievement of specific business objectives, and other
measurements of performance. Awards may be subject to restrictions and
contingencies regarding vesting and eventual payment as the Compensation
Committee may determine.
Terms of
Awards. All awards made under the 2010 Plan may be subject to vesting and
other contingencies as determined by the Compensation Committee and will be
evidenced by agreements approved by the Compensation Committee which set forth
the terms and conditions of each award. The Compensation Committee, in its
discretion, may accelerate or extend the period for the exercise or vesting of
any awards.
Generally, all awards, except
non-incentive stock options, granted under the 2010 Plan shall be
nontransferable except by will or in accordance with the laws of descent and
distribution or pursuant to a domestic relations order. During the life of the
participant, awards can be exercised only by the participant. The Compensation
Committee may permit a participant to designate a beneficiary to exercise or
receive any rights that may exist under the 2010 Plan upon the participant’s
death.
Change
in Control
Upon the occurrence of an event
constituting a change in control of the Company as defined in the 2010 Plan, all
awards outstanding will become immediately vested.
Tax
Consequences
The following are the federal tax
consequences generally arising with respect to awards granted under the 2010
Plan. The grant of an option will create no tax consequences for an optionee or
the Company. The optionee will have no taxable income upon exercising an
incentive stock option (except that the alternative minimum tax may apply), and
the Company will receive no deduction when an incentive stock option is
exercised. Upon exercising an option other than an incentive stock option, the
optionee must recognize ordinary income equal to the difference between the
exercise price and the fair market value of the stock on the date of exercise;
the Company will be entitled to a tax deduction for the same amount. The tax
treatment for an optionee on a disposition of shares acquired through the
exercise of an option depends on how long the shares have been held and whether
such shares were acquired by exercising an incentive stock option or by
exercising an option other than an incentive stock option. Generally, there will
be no tax consequences to the Company in connection with the disposition of
shares acquired under an option except that the Company may be entitled to a tax
deduction in the case of a disposition of shares acquired under the incentive
stock option before the applicable incentive stock option holding periods have
been satisfied.
With respect to other awards granted
under the 2010 Plan that are settled either in cash or in stock or other
property that is either transferable or not subject to substantial risk of
forfeiture, the participant must recognize ordinary income equal to the cash or
fair market value of shares and the Company will be entitled to a deduction for
the same amount. With respect to awards that are restricted as to
transferability or subject to substantial risk of forfeiture, the participant
must recognize ordinary income equal to the fair market value of the shares
received at the time the shares or other property became transferable or not
subject to substantial risk of forfeiture, whichever occurs earlier; the Company
will be entitled to a deduction for the same amount.
Use
of New Plan Benefits
The future benefits or amounts that
would be received under the 2010 Plan by executive officers and others are
discretionary and are therefore not determinable at this time. There
are currently no agreements or understandings regarding the issuance of any
options or shares under the 2010 Plan.
BENEFICIAL
OWNERSHIP OF OUR COMMON STOCK
As of February 1, 2010, we had a total
of 437,500 shares of common stock issued and outstanding. After
giving effect to the closing of the Exchange Agreement with Muscle Plarm, we
will have a total of 26,070,834 shares of common stock issued and
outstanding.
The following table sets forth, as of
February 1, 2010: (a) the names and addresses of each beneficial owner of more
than five percent (5%) of our common stock known to us, the number of shares of
common stock beneficially owned by each such person, and the percent of our
common stock so owned before and after the closing of the Exchange Agreement;
and (b) the names and addresses of each director and executive officer before
and after the closing of the Exchange Agreement, the number of shares of our
common stock beneficially owned, and the percentage of our common stock so
owned, by each such person, and by all of our directors and executive officers
as a group before and after the closing of the Exchange Agreement. Each person
has sole voting and investment power with respect to the shares of our common
stock, except as otherwise indicated. Beneficial ownership consists of a direct
interest in the shares of common stock, except as otherwise indicated.
Individual beneficial ownership also includes shares of common stock that a
person has the right to acquire within 60 days from February 1,
2010.
At the closing of the Exchange
Agreement, which will not happen until the expiration of the 10-day period
following the filing of the Rule 14f-1 Information Statement with the SEC and
mailing of the Information Statement to our shareholders, John Dean Harper will
resign as a director and be replaced by Brad Pyatt. In addition Cory
Gregory will become a director. John Dean Harper will also resign as
an officer ans Brad Pyatt, Cory Gregory, Todd E. Huss and Leonard K. Armenta,
Jr. will assume positions as officers of our Company.
Unless otherwise noted, the principal
address of each of the directors and officers listed below is 3390 Peoria
Street, Unit 307, Aurora, Colorado 80010.
|
|
Percentage
of
|
Share
Amount
|
|
|
Share
Amount
|
Outstanding
|
and
Nature of
|
Percentage
of
|
|
and
Nature
|
Shares
Before
|
Beneficial
|
Outstanding
|
|
of
Beneficial
|
the
Closing
|
Ownership
|
Shares
Before the
|
|
Ownership
Before
|
of
the
|
After
the Closing
|
Closing
of the
|
|
the
Closing of the
|
Exchange
|
of
the Exchange
|
Exchange
|
Name
|
Exchange Agreement
|
Agreement(1)
|
Agreement(2)
|
Agreement(2)
|
|
|
|
|
|
John
Dean Harper
|
366,666
|
84%
|
0
|
0
|
4301
S. Valley View Ave.
|
|
|
|
|
Suite
20
|
|
|
|
|
Las
Vegas, NV 89103
|
|
|
|
|
|
|
|
|
|
San
Nicholas, Inc. (3)
|
83,333(4)
|
16%
|
83,333
|
*
|
Escobedo
435 Ote
|
|
|
|
|
Torreon,
Coah
|
|
|
|
|
Mexico
|
|
|
|
|
|
|
|
|
|
Brad
Pyatt
|
0
|
0
|
12,331,668
|
47.3%
|
|
|
|
|
|
Cory
Gregory
|
0
|
0
|
7,833,014
|
30.0
%
|
422
Middleground Road
|
|
|
|
|
Pataskala,
Ohio 43062
|
|
|
|
|
|
|
|
|
|
Todd
E. Huss
|
0
|
0
|
0
|
0
|
13802
Boulder Lane
|
|
|
|
|
Larkspur,
Colorado 80118
|
|
|
|
|
|
|
|
|
|
Leonard
K. Armenta, Jr.
|
0
|
0
|
0
|
0
|
|
|
|
|
|
All
Directors and Executive
|
|
|
20,164,602
|
77.3%
|
Officers
as a group after the Closing of the Exchange
Agreement
|
|
|
|
|
_______________________
* Less
than one percent
(1)
|
The
numbers in this column are based on 437,500 shares
outstanding.
|
(2)
|
The
numbers are based on 26,070,834 shares outstanding, which represent the
number of shares the Company will have outstanding after the closing of
the Exchange Agreement warrants.
|
(3)
|
San
Nicholas, Inc., a Nevada corporation, is beneficially owned and controlled
by Mrs. Eva Esparza, Escobedo 435 Ote., Torreon, Coah,
Mexico.
|
(4)
|
San
Nicholas, Inc. has the right to acquire these shares within 60 days upon
the conversion of 416.67 shares of Series A Convertible Preferred Stock
held by San Nicholas, Inc. San Nicholas, Inc. owns a total of
83,333 shares of the Series A Convertible Preferred Stock and each share
is convertible into 200 shares of common stock; however, San Nicholas,
Inc. can only convert up to 416.67 shares of the preferred stock within
any 12 month period pursuant to a lock up letter with us. (See
Exhibit 10.1 to our Form 10-K filed on December 10,
2009.)
|
COMPENSATION
OF DIRECTORS AND EXECUTIVE OFFICERS
Executive
Compensation
No compensation has been paid and no
stock options granted to our sole officer and director in the last three fiscal
years.
Unless otherwise expressly provided by
resolution adopted by the Board of Directors, no director is entitled to receive
any compensation for his services as a director. The Board of Directors may
provide that the directors shall be paid a fixed sum for attendance at each
meeting of the Board of Directors or a stated salary as director. In addition,
the Board of Directors may provide that directors shall be paid their actual
expenses, if any, of attendance at each meeting of the Board of Directors. Our
bylaws do not prohibit any director from serving our Company in any other
capacity and receiving compensation, but the Board of Directors may by
resolution provide that any director receiving compensation for his or her
services to our Company in any other capacity shall not receive additional
compensation for his or her services as a director. The Board of Directors has
not adopted any policy in regard to the payment of fees or other compensation to
directors.
Muscle Pharm’s Director and
Officer Compensation
During
the years ended December 31, 2008 and December 31, 2009, the only form of
compensation paid to the executive officers of Muscle Pharm LLC was
cash. The table below lists the aggregate amount of the cash payments
that were made to executive officers during the years ended December 31, 2008
and December 31, 2009.
|
Total Cash Paid
|
|
Name and Principal Position
|
2008
|
2009
|
|
|
|
Brad
Pyatt - President
|
$16,125
|
$133,992
|
Cory
Gregory – Executive Vice President
|
3,000
|
17,846
|
Leonard
Armenta, Jr. – Chief Operating Officer
|
10,500
|
54,799
|
The
current annual salary levels of the executive officers are as
follows:
Brad
Pyatt
|
$193,992
|
Cory
Gregory
|
60,000
|
Leonard
Armenta
|
86,400
|
The new officers of the Company will
continue to receive their salary as set forth above after the closing of the
Exchange Agreement.
Certain Relationships and
Related Transactions of Tone in Twenty
Our sole officer/director has
contributed office space for our use at no charge. There have been no
other transactions with our sole officer/director.
Conflicts of
Interest
We have not adopted any policies or
procedures for the review, approval, or ratification of any transaction between
our Company and any executive officer, director, nominee to become a director,
10% stockholder, or family member of such persons, required to be reported under
paragraph (a) of Item 404 of Regulation S-K promulgated by the SEC.
Muscle Pharm Relationships
and Related Transactions
Muscle Pharm was formed as a Colorado
limited liability company on April 22, 2008. The initial owners of
Muscle Pharm were Brad Pyatt and Cory Gregory. Mr. Pyatt received a
60% membership interest in exchange for his contribution of formulations for
potential products, contacts with GNC Canada and other potential customers, and
contacts with professional athletes. Mr. Gregory received a 40%
membership interest in exchange for his contacts with Dr. Serrano, Louie
Simmons, potential distributors, professional athletes and potential
investors. Neither Mr. Pyatt nor Mr. Gregory contributed any cash and
no value was placed on their respective contributions.
FORWARD-LOOKING
STATEMENTS
This Information Statement includes
forward-looking statements within the meaning of Section 27A of the Securities
Act and Section 21E of the Exchange Act. You can identify our forward-looking
statements by the words “expects,” “projects,” “believes,” “anticipates,”
“intends,” “plans,” “predicts,” “estimates” and similar
expressions.
The forward-looking statements are
based on management’s current expectations, estimates and projections about us.
The Company cautions you that these statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that we cannot
predict. In addition, the Company has based many of these forward-looking
statements on assumptions about future events that may prove to be inaccurate.
Accordingly, actual outcomes and results may differ materially from what the
Company has expressed or forecast in the forward-looking
statements.
You should rely only on the information
the Company has provided in this Information Statement. The Company has not
authorized any person to provide information other than that provided herein.
The Company has not authorized anyone to provide you with different information.
You should not assume that the information in this Information Statement is
accurate as of any date other than the date on the front of the
document.
STOCKHOLDER
PROPOSALS
The Company’s Board of Directors has
not yet determined the date on which the next annual meeting of stockholders
will be held. Any proposal by a stockholder intended to be presented at the
Company’s next annual meeting of stockholders must be received at the Company’s
offices a reasonable amount of time prior to the date on which the information
or proxy statement for that meeting is mailed to stockholders in order to be
included in the Company’s information or proxy statement relating to that
meeting.
DELIVERY
OF DOCUMENTS AND HOUSEHOLDING
The Commission has adopted rules that
permit companies and intermediaries such as brokers, to satisfy the delivery
requirements for information statements with respect to two or more
securityholders sharing the same address by delivering a single information
statement addressed to those securityholders. This process, which is commonly
referred to as “householding,” provides potentially extra convenience for
stockholders, is environmental friendly, and represents cost savings for
companies.
For this Information Statement, a
number of brokers with account holders who are the Company’s stockholders will
be “householding” this Information Statement and the documents incorporated by
reference that we are enclosing with the Information Statement. A single
Information Statement will be delivered to multiple stockholders sharing an
address unless contrary instructions have been received from the effected
stockholders. Once you have received notice from your broker or from the Company
that either of them will be “householding” communications to your address,
“householding” will continue until you are notified otherwise or until you
revoke your consent.
If at any time, you no longer wish to
participate in “householding” and would prefer to receive separate periodic
reports, or if you currently receive multiple copies of the Information
Statement or other periodic reports at your address and would like to request
“householding” by the Company, please notify your broker if your shares are not
held directly in your name. If you own your shares directly rather then through
a brokerage account, you should direct your written request directly to the
Corporate Secretary, Tone in Twenty, 3433Losee Rd., Suite 2, North Las Vegas,
NV 89030.
DOCUMENTS
INCORPORATED BY REFERENCE
In our filings with the SEC,
information is sometimes “incorporated by reference.” This means that we may
disclose important information to you by referring you to another document filed
separately with the SEC. The information incorporated by reference is deemed to
be part of this Information Statement, except for any information that is
superseded or modified by information contained directly in this Information
Statement or in any other subsequently filed document that is also incorporated
by reference herein. This Information Statement incorporates by reference the
information set forth below that the Company has previously filed with the SEC
and that is being delivered to you along with this Information
Statement.
The following information contained in
our Current Report on Form 8-K, as filed with the Securities and Exchange
Commission on February 2, 2010 is incorporated by reference herein:
(1) Securities
Exchange Agreement By and Among Tone in Twenty, Muscle Pharm LLC, and the
Security Holders of Muscle Pharm LLC.
A copy of
the 2010 Stock Incentive Plan is attached as Exhibit A.
By Order
of the Board of Directors
______________________________
John Dean
Harper
President
EXHIBIT
A
MUSCLE
PHARM, LLC
2010
STOCK INCENTIVE PLAN
SECTION
1.
PURPOSE
The
purpose of this Plan is to promote the growth and prosperity of the Company and
its Subsidiaries by providing Eligible Recipients with an additional incentive
to contribute to the Company's success, by assisting the Company in attracting
and retaining the best available personnel for positions of substantial
responsibility and by increasing the identity of interests of Eligible
Recipients with those of the Company's shareholders. The Plan provides for the
grant of Incentive Stock Options, Non Qualified Stock Options, Restricted Stock
Awards, Restricted Stock Units and Stock Appreciation Rights to aid the Company
in obtaining these goals. The Plan, as well as any amendments thereto that
require Shareholder approval, will be submitted to the Company's shareholders
for their approval at the next shareholder meeting.
SECTION
2.
DEFINITIONS
As
used in this Plan and any Stock Incentive Agreement, the following terms shall
have the following meanings:
2.1 BOARD
means the Board of Directors of the Company.
2.2 CAUSE
shall mean, with respect to any Participant who is a member of the Board who is
not an employee of the Company, a termination of employment or service on the
Board (by removal or failure of the Board to nominate the Participant) whenever
occasioned by (a) the willful and continued failure by the Participant to
substantially perform the Participant's duties with the Company or a Subsidiary
(other than any such failure resulting from the Participant's incapacity due to
physical or mental illness) after a written demand for substantial performance
is delivered to the Participant by the Board, which demand specifically
identifies the manner in which the Board believes the Participant has not
substantially performed the Participant's duties, or (b) the willful engaging by
the Participant in conduct which is demonstrably and materially injurious to the
Company or its Subsidiaries, monetarily or otherwise. For purposes of this
definition, no act, or failure to act, on the Participant's part shall be deemed
"willful" unless done, or omitted to be done, by the Participant not in good
faith and without reasonable belief that the Participant's act, or failure to
act, was in the best interest of the Company.
2.3 CHANGE
OF CONTROL means any of the following:
(a) any
"person" as such term is used in Sections 13(d) and 14(d) of the Exchange Act
(other than the Company, any trustee or other fiduciary holding securities under
an employee benefit plan of the Company or any company owned, directly or
indirectly, by the shareholders of the Company in substantially the same
proportions as their ownership of stock of the Company), becomes the "beneficial
owner" (as defined in Rule 13d 3 under the Exchange Act), directly or
indirectly, of securities of the Company representing 50% or more of the
combined voting power of the Company's then outstanding securities;
or
(b) during
any period of two (2) consecutive years (not including any period prior to the
effective date of this Plan); individuals who at the beginning of such period
constitute the Board, and any new member of the Board (other than a member of
the Board designated by a person who has entered into an agreement with the
Company to effect a transaction described in subsections (a), (b) or (c) of this
Section) whose election by the Company's shareholders was approved by a vote of
at least two thirds (2/3) of the members of the Board at the beginning of the
period or whose election or nomination for election was previously so approved,
cease for any reason to constitute at least a majority thereof; or
(c) the
shareholders of the Company approve a merger or consolidation of the Company
with any other Company, other than (1) a merger or consolidation which would
result in the voting securities of the Company outstanding immediately prior
thereto continuing to represent (either by remaining outstanding or by being
converted into voting securities of the surviving entity) more than 50% of the
combined voting power of the voting securities of the Company or such surviving
entity outstanding immediately after such merger or consolidation or (2) a
merger or consolidation effected to implement a recapitalization of the Company
(or similar transaction) in which no "person" (as herein defined) acquires more
than 50% of the combined voting power of the Company's then outstanding
securities; or
(d) the
shareholders of the Company approve a plan of liquidation, dissolution or
winding up of the Company or an agreement for the sale or disposition by the
Company of all or substantially all of the Company's assets.
2.4 CODE
means the Internal Revenue Code of 1986, as amended.
2.5 COMMITTEE
means the Compensation Committee of the Board or any other committee appointed
by the Board to administer the Plan, as specified in Section 5 hereof. Any such
committee must be comprised entirely of Outside Directors who are "independent"
as that term is defined in the rules of the the Securities and Exchange
Commission, and the listing standards of the stock exchange or other market upon
which the Company's stock is listed or quoted, as the same may be amended from
time to time.
2.6 COMMON
STOCK means the $.0001 par value common stock of the Company.
2.7 COMPANY
means MusclePharm Corporation, a Nevada corporation, and any successor to such
organization.
2.8 DISABILITY
shall mean disability as determined by the Committee in its sole and absolute
discretion.
2.9 ELIGIBLE
RECIPIENT means a Key Employee and/or a Key Person.
2.10
EXCHANGE ACT means the Securities Exchange Act of 1934, as amended.
2.11
EXERCISE PRICE means the price that shall be paid to purchase one (1) Share upon
the exercise of an Option granted under this Plan.
2.12
FAIR MARKET VALUE of a Share on any date means the mean between the highest and
lowest reported selling prices on a national securities exchange of a Share as
reported in the appropriate composite listing for said exchange on such date,
or, if no such sales occurred on such date, then on the next preceding date on
which a sale is made. In the event the Shares are traded in the over the counter
market, Fair Market Value of a Share means the mean between the "high" and "low"
quotations in the over the counter market on such date, as reported by the
National Association of Securities Dealers through NASDAQ or, if no quotations
are available on such date, then on the next preceding date on which such
quotations are available.
2.13
INSIDER means an individual who is, on the relevant date, an officer, member of
the Board or ten percent (10%) beneficial owner of any class of the Company's
equity securities that is registered pursuant to Section 12 of the Exchange Act,
all as defined under Section 16 of the Exchange Act.
2.14
INDEPENDENT DIRECTOR means a director who is determined to be "independent" as
that term is defined by the Securities and Exchange Commission, and the listing
standards of stock exchange or market upon which the Company's stock is listed
or quoted as the same may be amended from time to time.
2.15
ISO means an option granted under this Plan to purchase Shares that is intended
by the Company to satisfy the requirements of Code Section 422 as an incentive
stock option.
2.16
KEY EMPLOYEE means any employee of the Company or any Subsidiary, regardless of
title or designation, as shall, in the determination of the Committee, hold a
position which is important to the success of the Company.
2.17
KEY PERSON means (1) a member of the Board who is not an employee, or (2) a
consultant, advisor or service provider who is eligible to receive shares which
are registered on SEC Form S -8.
2.18
NQSO means an option granted under this Plan to purchase Shares which is not
intended by the Company to satisfy the requirements of Code Section
422.
2.19
OPTION means an ISO or a NQSO.
2.20
OUTSIDE DIRECTOR means a member of the Board who is not a Key Employee and who
qualifies as (1) a "non employee director" under Rule 16b -3(b)(3) under the
1934 Act, as amended from time to time, and (2) an "outside director" under Code
Section 162(m) and the regulations promulgated thereunder.
2.21
PARTICIPANT means an individual who receives a Stock Incentive
hereunder.
2.22
PERFORMANCE BASED EXCEPTION means the performance based exception from the tax
deductibility limitations of Code Section 162(m).
2.23
PERFORMANCE PERIOD shall mean the period during which a performance goal must be
attained with respect to a Stock Incentive which is performance based, as
determined by the Committee pursuant to Section 14.3 hereof.
2.24
PLAN means this plan, 2010 Stock Incentive Plan, as it may be further amended
from time to time.
2.25
QUALIFYING EVENT shall mean, with respect to a Participant, such Participant's
death, Disability or Retirement.
2.26
RESTRICTED STOCK AWARD means an award of Shares granted to a Participant under
this Plan which is subject to restrictions in accordance with the terms and
provisions of this Plan and the applicable Stock Incentive
Agreement.
2.27
RESTRICTED STOCK UNIT means a contractual right granted to a Participant under
this Plan to receive a Share (or cash equivalent) which is subject to
restrictions of this Plan and the applicable Stock Incentive
Agreement.
2.28
RETIREMENT shall mean, with respect to an Eligible Recipient, such Eligible
Recipient's (i) termination of employment or cessation of performing services
after attainment of age 60 and completion of at least fifteen (15) years of
service with the Company or Subsidiary, or (ii) termination of employment or
cessation of performing services after attainment of age 65 and completion of at
least five (5) years of service with the Company or a Subsidiary.
2.29
SHARE means a share of Common Stock.
2.30
STOCK APPRECIATION RIGHT means a right granted to a Participant pursuant to the
terms and provisions of this Plan whereby the individual, without payment to the
Company (except for any applicable withholding or other taxes), receives Shares,
or such other consideration as the Committee may determine, in an amount equal
to the excess of the Fair Market Value per Share on the date on which the Stock
Appreciation Right is exercised over the exercise price per Share noted in the
Stock Appreciation Right, for each Share subject to the Stock Appreciation
Right.
2.31
STOCK INCENTIVE means an ISO, a NQSO, a Restricted Stock Award, a Restricted
Stock Unit or a Stock Appreciation Right.
2.32
STOCK INCENTIVE AGREEMENT means a document issued by the Company or a Subsidiary
to a Participant evidencing an award of a Stock Incentive.
2.33
SUBSIDIARY means any corporation in which more than fifty percent (50%) of the
voting stock is owned or controlled, directly or indirectly, by the
Company.
2.34
TEN PERCENT SHAREHOLDER means a person who owns (after taking into account the
attribution rules of Code Section 424(d)) more than ten percent (10%) of the
total combined voting power of all classes of shares of stock of either the
Company or a Subsidiary.
SECTION
3.
SHARES
SUBJECT TO STOCK INCENTIVES
The
total number of Shares that may be issued pursuant to Stock Incentives under
this Plan shall not exceed Five Million (5,000,000), of which any number may be
used for Restricted Stock Awards and Restricted Stock Units, as adjusted
pursuant to Section 10. Such Shares shall be reserved, to the extent that the
Company deems appropriate, from authorized but unissued Shares, and from Shares
which have been reacquired by the Company. To the extent permitted by applicable
law or regulation, if a Stock Incentive is canceled, forfeited, exchanged or
otherwise expires the Shares with respect to such Stock Incentive may become
available for reissuance under this Plan.
SECTION
4.
EFFECTIVE
DATE
The
effective date of this Plan shall be __________, 2010, which is the date on
which the Board of Directors of the Company originally approved the Plan. Such
date is subject to the Company's shareholders approving the Plan within twelve
months of such date.
SECTION
5.
ADMINISTRATION
5.1 GENERAL
ADMINISTRATION. This Plan shall be administered by the Committee. The Committee,
acting in its absolute discretion, shall exercise such powers and take such
action as expressly called for under this Plan. The Committee shall have the
power to interpret this Plan and, subject to the terms and provisions of this
Plan, to take such other action in the administration and operation of the Plan
as it deems equitable under the circumstances. The Committee's actions shall be
binding on the Company, on each affected Eligible Recipient, and on each other
person directly or indirectly affected by such actions.
5.2 AUTHORITY
OF THE COMMITTEE. Except as limited by law or by the Articles of Incorporation
of the Company, and subject to the provisions herein, the Committee shall have
full power to select Eligible Recipients who shall participate in the Plan, to
determine the sizes and types of Stock Incentives in a manner consistent with
the Plan, to determine the terms and conditions of Stock Incentives in a manner
consistent with the Plan, to construe and interpret the Plan and any agreement
or instrument entered into under the Plan, to establish, amend or waive rules
and regulations for the Plan's administration, and to amend the terms and
conditions of any outstanding Stock Incentives as allowed under the Plan and
such Stock Incentives. Further, the Committee may make all other determinations
which may be necessary or advisable for the administration of the Plan. The
Committee may seek the assistance of such persons as it may see fit in carrying
out its routine administrative functions concerning the Plan.
5.3 DELEGATION
OF AUTHORITY. The members of the Committee and any other persons to whom
authority has been delegated shall be appointed from time to time by, and shall
serve at the discretion of, the Board. The Committee may appoint one or more
separate committees (any such committee, a "Subcommittee") composed of two or
more Outside Directors of the Company (who may but need not be members of the
Committee) and may delegate to any such Subcommittee the authority to grant
Stock Incentives, and/or to administer the Plan or any aspect of it.
Notwithstanding any provision of this Plan to the contrary, the Board may assume
the powers and responsibilities granted to the Committee or other delegate at
any time, in whole or in part. Moreover, only the Committee may grant Stock
Incentives that may meet the Performance Based Exception, and only the Committee
may grant Stock Incentives to Insiders that may be exempt from Section 16(b) of
the Exchange Act.
5.4 DECISIONS
BINDING. All determinations and decisions made by the Committee pursuant to the
provisions of this Plan and all related orders and resolutions of the Committee
shall be final, conclusive and binding on all persons, including the Company,
its shareholders, members of the Board, Eligible Recipients, Participants, and
their estates and beneficiaries.
SECTION
6.
ELIGIBILITY
Eligible
Recipients selected by the Committee shall be eligible for the grant of Stock
Incentives under this Plan, but no Eligible Recipient shall have the right to be
granted a Stock Incentive under this Plan merely as a result of his or her
status as an Eligible Recipient. Only Key Employees shall be eligible to receive
a grant of ISOs.
SECTION
7.
TERMS OF
STOCK INCENTIVES
7.1 TERMS
AND CONDITIONS OF ALL STOCK INCENTIVES.
(a) Grants
of Stock Incentives. Subject to subsection (e) below, the Committee, in its
absolute discretion, shall grant Stock Incentives under this Plan from time to
time and shall have the right to grant new Stock Incentives in exchange for
outstanding Stock Incentives; provided, however, the Committee shall not have
the right to (1) lower the Exercise Price of an existing Option, (2) take any
action which would be treated as a "repricing" under generally accepted
accounting principles, or (3) canceling of an existing Option at a time when its
Exercise Price exceeds the fair market value of the underlying stock subject to
such Option in exchange for another Option, a Restricted Stock Award, or other
equity in the Company (except as provided in Sections 10 and 11). Stock
Incentives shall be granted to Eligible Recipients selected by the Committee,
and the Committee shall be under no obligation whatsoever to grant any Stock
Incentives, or to grant Stock Incentives to all Eligible Recipients, or to grant
all Stock Incentives subject to the same terms and conditions.
(b) Shares
Subject to Stock Incentives. The number of Shares as to which a Stock Incentive
shall be granted shall be determined by the Committee in its sole discretion,
subject to the provisions of Section 3 as to the total number of Shares
available for grants under the Plan, and to any other restrictions contained in
this Plan.
(c) Stock
Incentive Agreements. Each Stock Incentive shall be evidenced by a Stock
Incentive Agreement executed by the Company or a Subsidiary, and may also be
executed by the Participant or accepted by the Participant by electronic
transmission, which shall be in such form and contain such terms and conditions
as the Committee in its discretion may, subject to the provisions of the Plan,
from time to time determine.
(d) Date
of Grant. The date a Stock Incentive is granted shall be the date on which the
Committee (1) has approved the terms and conditions of the Stock Incentive
Agreement, (2) has determined the recipient of the Stock Incentive and the
number of Shares covered by the Stock Incentive and (3) has taken all such other
action necessary to direct the grant of the Stock Incentive.
(e) Dividend
Equivalents. The Committee may grant dividend equivalents to any Participant.
The Committee shall establish the terms and conditions to which the dividend
equivalents are subject. Dividend equivalents may be granted only in connection
with a Stock Incentive. Under a dividend equivalent, a Participant shall be
entitled to receive currently or in the future payments equivalent to the amount
of dividends paid by the Company to holders of Common Stock with respect to the
number of dividend equivalents held by the Participant. The dividend equivalent
may provide for payment in Common Stock or in cash, or a fixed combination of
Common Stock or cash, or the Committee may reserve the right to determine the
manner of payment at the time the dividend equivalent is payable.
(f) Deferral
Elections. The Committee may permit or require Participants to elect to defer
the issuance of Common Stock or the settlement of awards in cash under this Plan
pursuant to such rules, procedures, or programs as it may establish from time to
time. However, notwithstanding the preceding sentence, the Committee shall not,
in establishing the terms and provisions of any Stock Incentive, or in
exercising its powers under this Article, create any arrangement which would
constitute an employee pension benefit plan as defined in ERISA Section 3(3)
unless the arrangement provides benefits solely to one or more individuals who
constitute members of a select group of management or highly compensated
employees.
7.2 TERMS
AND CONDITIONS OF OPTIONS.
(a) Grants
of Options. Each grant of an Option shall be evidenced by a Stock Incentive
Agreement that shall specify whether the Option is an ISO or NQSO, and
incorporate such other terms as the Committee deems consistent with the terms of
this Plan and, in the case of an ISO, necessary or desirable to permit such
Option to qualify as an ISO. The Committee and/or the Company may modify the
terms and provisions of an Option in accordance with Section 12 of this Plan
even though such modification may change the Option from an ISO to a
NQSO.
(b) Determining
Optionees. In determining Eligible Recipient(s) to whom an Option shall be
granted and the number of Shares to be covered by such Option, the Committee may
take into account the duties of the Eligible Recipient, the contributions of the
Eligible Recipient to the success of the Company, and other factors deemed
relevant by the Committee, in connection with accomplishing the purpose of this
Plan. An Eligible Recipient who has been granted an Option to purchase Shares,
whether under this Plan or otherwise, may be granted one or more additional
Options. If the Committee grants an ISO and a NQSO to an Eligible Recipient on
the same date, the right of the Eligible Recipient to exercise one such Option
shall not be conditioned on the Eligible Recipient's failure to exercise the
other such Option.
(c) Exercise
Price. Subject to adjustment in accordance with Section 10 and the other
provisions of this Section, the Exercise Price shall be specified in the
applicable Stock Incentive Agreement. With respect to each grant of an ISO to a
Participant who is not a Ten Percent Shareholder, the Exercise Price shall not
be less than the Fair Market Value of a Share on the date the ISO is granted.
With respect to each grant of an ISO to a Participant who is a Ten Percent
Shareholder, the Exercise Price shall not be less than one hundred ten percent
(110%) of the Fair Market Value of a Share on the date the ISO is granted. If a
Stock Incentive is a NQSO, the Exercise Price for each Share shall be no less
than (1) the minimum price required by applicable state law, or (2) the Fair
Market Value of a Share on the date the NQSO is granted, whichever price is
greatest. Any Stock Incentive intended to meet the Performance Based Exception
must be granted with an Exercise Price not less than the Fair Market Value of a
Share determined as of the date of such grant.
(d) Option
Term. Each Option granted under this Plan shall be exercisable in whole or in
part at such time or times as set forth in the related Stock Incentive
Agreement, but no Stock Incentive Agreement shall:
(i) make
an Option exercisable prior to the date such Option is granted or after it has
been exercised in full; or
(ii) make
an Option exercisable after the date that is (A) the tenth (10th) anniversary of
the date such Option is granted, if such Option is a NQSO or an ISO granted to a
non Ten Percent Shareholder, or (B) the date that is the fifth (5th) anniversary
of the date such Option is granted, if such Option is an ISO granted to a Ten
Percent Shareholder. Options issued under the Plan may become exercisable based
on the service of a Participant, or based upon the attainment (as determined by
the Committee) of performance goals established pursuant to one or more of the
performance criteria listed in Section 14. Any Option which becomes exercisable
based on the attainment of performance goals must have its performance goals
determined by the Committee based upon one or more of the performance criteria
listed in Section 14, and must have the attainment of such performance goals
certified in writing by the Committee in order to meet the Performance Based
Exception. A Stock Incentive Agreement may provide for the exercise of an Option
after the employment of a Key Employee has terminated for any reason whatsoever,
including the occurrence of a Qualifying Event. The Key Employee's rights, if
any, upon termination of employment will be set forth in the applicable Stock
Incentive Agreement.
(e) Payment.
Options shall be exercised by the delivery of a written notice of exercise to
the Company, specifying the number of Shares with respect to which the Option is
to be exercised accompanied by full payment for the Shares. Payment for shares
of Stock shall be made in cash or, unless the Stock Incentive Agreement provides
otherwise, by delivery to the Company of a number of Shares that have been owned
and completely paid for by the holder for at least six (6) months prior to the
date of exercise (i.e., "mature shares" for accounting purposes) having an
aggregate Fair Market Value equal to the amount to be tendered, or a combination
thereof. In addition, unless the Stock Incentive Agreement provides otherwise,
the Option may be exercised through a brokerage transaction as permitted under
the provisions of Regulation T applicable to cashless exercises promulgated by
the Federal Reserve Board so long as the Company's equity securities are
registered under Section 12 of the Exchange Act, unless prohibited by Section
402 of the Sarbanes Oxley Act of 2002. Notwithstanding the foregoing,
with
respect
to any Option recipient who is an Insider, a tender of shares or, if permitted
by applicable law, a cashless exercise must (1) have met the requirements of an
exemption under Rule 16b -3 promulgated under the Exchange Act, or (2) be a
subsequent transaction the terms of which were provided for in a transaction
initially meeting the requirements of an exemption under Rule 16b -3 promulgated
under the Exchange Act. Unless the Stock Incentive Agreement provides otherwise,
the foregoing exercise payment methods shall be subsequent transactions approved
by the original grant of an Option. Except as provided in subparagraph (f)
below, payment shall be made at the time that the Option or any part thereof is
exercised, and no Shares shall be issued or delivered upon exercise of an Option
until full payment has been made by the Participant. The holder of an Option, as
such, shall have none of the rights of a shareholder.
(f) Conditions
to Exercise of an Option. Each Option granted under the Plan shall vest and
shall be exercisable at such time or times, or upon the occurrence of such event
or events, and in such amounts, as the Committee shall specify in the Stock
Incentive Agreement; provided, however, that subsequent to the grant of an
Option, the Committee, at any time before complete termination of such Option,
may accelerate the time or times at which such Option may vest or be exercised
in whole or in part. The Committee may impose such restrictions on any Shares
acquired pursuant to the exercise of an Option as it may deem advisable. Unless
otherwise provided in the applicable Stock Incentive Agreement, any vested
Option must be exercised within ninety (90) days of the Qualifying Event or
other termination of employment of the Participant, unless, in case of an NQSO,
by action of the Committee coincident with the Qualifying Event or other
termination of employment, the term of exercise is extended to no later than the
original expiration date of such NQSO.
(g) Transferability
of Options. Except as otherwise provided in a Participant's Stock Incentive
Agreement, no Option granted under the Plan may be sold, transferred, pledged,
assigned or otherwise alienated or hypothecated, except upon the death of the
holder Participant by will or by the laws of descent and distribution. Except as
otherwise provided in a Participant's Stock Incentive Agreement, during the
Participant's lifetime, only the Participant may exercise his Option unless the
Participant is incapacitated in which case the Option may be exercised by the
Participant's legal guardian, legal representative, or other representative whom
the Committee deems appropriate based on applicable facts and circumstances. The
determination of incapacity of a Participant and the identity of appropriate
representative of the Participant to exercise the Option if the Participant is
incapacitated shall be determined by the Committee.
(h) ISO
Tax Treatment Requirements. With respect to any Option that purports to be an
ISO, to the extent that the aggregate Fair Market Value (determined as of the
date of grant of such Option) of stock with respect to which such Option is
exercisable for the first time by any individual during any calendar year
exceeds one hundred thousand dollars ($100,000.00), to the extent of such
excess, such Option shall not be treated as an ISO in accordance with Code
Section 422(d). The rule of the preceding sentence is applied as set forth in
Treas. Reg. Section 1.422 -4 and any additional guidance issued by the Treasury
thereunder. Also, with respect to any Option that purports to be an ISO, such
Option shall not be treated as an ISO if the Participant disposes of shares
acquired thereunder within two (2) years from the date of the granting of the
Option or within one (1) year of the exercise of the Option, or if the
Participant has not met the requirements of Code Section
422(a)(2).
7.3 TERMS
AND CONDITIONS OF RESTRICTED STOCK AWARDS.
(a) Grants
of Restricted Stock Awards. Shares awarded pursuant to Restricted Stock Awards
shall be subject to such restrictions as determined by the Committee for periods
determined by the Committee. Restricted Stock Awards issued under the Plan may
have restrictions which lapse based upon the service of a Participant, or based
upon other criteria that the Committee may determine appropriate. The Committee
may require a cash payment from the Participant in exchange for the grant of a
Restricted Stock Award or may grant a Restricted Stock Award without the
requirement of a cash payment. The Committee may grant Restricted Stock Awards
that vest on the attainment of performance goals determined by the Committee
based upon one or more of the performance criteria listed in Section 14, and
must have the attainment of such performance goals certified in writing by the
Committee in order to meet the Performance Based Exception.
(b) Vesting
of Restricted Stock Awards. The Committee shall establish the vesting schedule
applicable to Restricted Stock Awards and shall specify the times, vesting and
performance goal requirements. Until the end of the period(s) of time specified
in the vesting schedule and/or the satisfaction of any performance criteria, the
Shares subject to such Stock Incentive Award shall remain subject to
forfeiture.
(c) Termination
of Employment. If the Participant's employment (or in the case of a non
employee, such Participant's service) with the Company and/or a Subsidiary ends
before the Restricted Stock Awards vest, the Participant shall forfeit all
unvested Restricted Stock Awards, unless the termination is a result of the
occurrence of a Qualifying Event or the Committee determines that the
Participant's unvested Restricted Stock Awards shall vest as of the date of such
event; provided, however, the Committee may grant Restricted Stock Awards
precluding such accelerated vesting in order to qualify the Restricted Stock
Awards for the Performance Based Exception.
(d) Death,
Disability and Retirement. In the event a Qualifying Event occurs before the
date or dates on which Restricted Stock Awards vest, the expiration of the
applicable restrictions (other than restrictions based on performance criteria
set forth in Section 14) shall be accelerated and the Participant shall be
entitled to receive the Shares free of all such restrictions. In the case of
Restricted Stock Awards which are based on performance criteria set forth in
Section 14, then as of the date on which such Qualifying Event occurs, the
Participant shall be entitled to receive a number of Shares that is determined
by measuring the selected performance criteria from the Company's most recent
publicly available quarterly results that are available as of the date the
Qualifying Event occurs; provided, however, the Committee may grant Restricted
Stock Awards precluding such partial awards when a Qualifying Event occurs in
order to qualify the Restricted Stock Awards for the Performance Based
Exception. All other Shares subject to such Restricted Stock Award shall be
forfeited and returned to the Company as of the date on which such Qualifying
Event occurs.
(e) Acceleration
of Award. Notwithstanding anything to the contrary in this Plan, the Committee
shall have the power to permit, in its sole discretion, an acceleration of the
expiration of the applicable restrictions or the applicable period of such
restrictions with respect to any part or all of the Shares awarded to a
Participant; provided, however, the Committee may grant Restricted Stock Awards
precluding such accelerated vesting in order to qualify the Restricted Stock
Awards for the Performance Based Exception.
(f) Necessity
of Stock Incentive Agreement. Each grant of a Restricted Stock Award shall be
evidenced by a Stock Incentive Agreement that shall specify the terms,
conditions and restrictions regarding the Shares awarded to a Participant, and
shall incorporate such other terms and conditions as the Committee, acting in
its sole discretion, deems consistent with the terms of this Plan. The Committee
shall have sole discretion to modify the terms and provisions of Restricted
Stock Awards in accordance with Section 12 of this Plan.
(g) Transferability
of Restricted Stock Awards. Except as otherwise provided in a Participant's
Restricted Stock Award, no Restricted Stock Award granted under the Plan may be
sold, transferred, pledged, assigned or otherwise alienated or hypothecated,
except upon the death of the holder Participant by will or by the laws of
descent and distribution.
(h) Voting,
Dividend & Other Rights. Unless the applicable Stock Incentive Agreement
provides otherwise, holders of Restricted Stock Awards shall be entitled to vote
and to receive dividends during the periods of restriction of their Shares to
the same extent as such holders would have been entitled if the Shares were
unrestricted Shares.
7.4 TERMS
AND CONDITIONS OF RESTRICTED STOCK UNITS.
(a) Grants
of Restricted Stock Units. A Restricted Stock Unit shall entitle the Participant
to receive one Share at such future time and upon such terms as specified by the
Committee in the Stock Incentive Agreement evidencing such award. Restricted
Stock Units issued under the Plan may have restrictions which lapse based upon
the service of a Participant, or based upon other criteria that the Committee
may determine appropriate. The Committee may require a cash payment from the
Participant in exchange for the grant of Restricted Stock Units or may grant
Restricted Stock Units without the requirement of a cash payment. The Committee
may grant Restricted Stock Units that vest on the attainment of performance
goals determined by the Committee based upon one or more of the performance
criteria listed in Section 14, and must have the attainment of such performance
goals certified in writing by the Committee in order to meet the Performance
Based Exception.
(b) Vesting
of Restricted Stock Units. The Committee shall establish the vesting schedule
applicable to Restricted Stock Units and shall specify the times, vesting and
performance goal requirements. Until the end of the period(s) of time specified
in the vesting schedule and/or the satisfaction of any performance criteria, the
Restricted Stock Units subject to such Stock Incentive Award shall remain
subject to forfeiture.
(c) Termination
of Employment. If the Participant's employment with the Company and/or a
Subsidiary ends before the Restricted Stock Units vest, the Participant shall
forfeit all unvested Restricted Stock Units, unless the termination is a result
of the occurrence of a Qualifying Event or the Committee determines that the
Participant's unvested Restricted Stock Units shall vest as of the date of such
event; provided, however, the Committee may grant Restricted Stock Units
precluding such accelerated vesting in order to qualify the Restricted Stock
Units for the Performance Based Exception.
(d) Death,
Disability and Retirement. In the event a Qualifying Event occurs before the
date or dates on which Restricted Stock Units vest, the expiration of the
applicable restrictions (other than restrictions based on performance criteria
set forth in Section 14) shall be accelerated and the Participant shall be
entitled to receive the Shares free of all such restrictions. In the case of
Restricted Stock Units which are based on performance criteria set forth in
Section 14, then as of the date on which such Qualifying Event occurs, the
Participant shall be entitled to receive a number of Shares that is determined
by measuring the selected performance criteria from the Company's most recent
publicly available quarterly results that are available as of the date the
Qualifying Event occurs; provided, however, the Committee may grant Restricted
Stock Units precluding such partial awards when a Qualifying Event occurs in
order to qualify the Restricted Stock Units for the Performance Based Exception.
All other Shares subject to such Restricted Stock Units shall be forfeited and
returned to the Company as of the date on which such Qualifying Event
occurs.
(e) Acceleration
of Award. Notwithstanding anything to the contrary in this Plan, the Committee
shall have the power to permit, in its sole discretion, an acceleration of the
applicable restrictions or the applicable period of such restrictions with
respect to any part or all of the Restricted Stock Units awarded to a
Participant; provided, however, the Committee may grant Restricted Stock Units
precluding such accelerated vesting on order to qualify the Restricted Stock
Units for the Performance Based Exception.
(f) Necessity
of Stock Incentive Agreement. Each grant of Restricted Stock Unit(s) shall be
evidenced by a Stock Incentive Agreement that shall specify the terms,
conditions and restrictions regarding the Participant's right to receive
Share(s) in the future, and shall incorporate such other terms and conditions as
the Committee, acting in its sole discretion, deems consistent with the terms of
this Plan. The Committee shall have sole discretion to modify the terms and
provisions of Restricted Stock Unit(s) in accordance with Section 12 of this
Plan.
(g) Transferability
of Restricted Stock Units. Except as otherwise provided in a Participant's
Restricted Stock Unit Award, no Restricted Stock Unit granted under the Plan may
be sold, transferred, pledged, assigned or otherwise alienated or hypothecated
by the holder Participant, except upon the death of the holder Participant by
will or by the laws of descent and distribution.
(h) Voting,
Dividend & Other Rights. Unless the applicable Stock Incentive Agreement
provides otherwise, holders of Restricted Stock Units shall not be entitled to
vote or to receive dividends until they become owners of the Shares pursuant to
their Restricted Stock Units, and, unless the applicable Stock Incentive
Agreement provides otherwise, the holder of a Restricted Stock Unit shall not be
entitled to any dividend equivalents (as described in Section
7.1(e)).
7.5 TERMS
AND CONDITIONS OF STOCK APPRECIATION RIGHTS.
(a) Grants
of Stock Appreciation Rights. A Stock Appreciation Right shall entitle the
Participant to receive upon exercise or payment the excess of the Fair Market
Value of a specified number of Shares at the time of exercise, over a specified
price. The specified price for a Stock Appreciation Right granted in connection
with a previously or
contemporaneously
granted Option, shall not be less than the Exercise Price for Shares that are
the subject of the Option. In the case of any other Stock Appreciation Right,
the specified price shall not be less than one hundred percent (100%) of the
Fair Market Value of the Shares at the time the Stock Appreciation Right was
granted. If related to an Option, the exercise of a Stock Appreciation Right
shall result in a pro rata surrender of the related Option to the extent the
Stock Appreciation Right has been exercised.
(b) Payment.
Upon exercise or payment of a Stock Appreciation Right, the Company shall pay to
the Participant the appreciation with Shares (computed using the aggregate Fair
Market Value of Shares on the date of payment or exercise) as specified in the
Stock Incentive Agreement or, if not specified, as the Committee determines. To
the extent that a Stock Appreciation Right is paid with consideration other than
Shares, it shall be treated as paid in Shares for purposes of Section
3.
(c) Vesting
of Stock Appreciation Rights. The Committee shall establish the vesting schedule
applicable to Stock Appreciation Rights and shall specify the times, vesting and
performance goal requirements. Until the end of the period(s) of time specified
in the vesting schedule and/or the satisfaction of any performance criteria, the
Stock Appreciation Rights subject to such Stock Incentive Award shall remain
subject to forfeiture.
(d) Death,
Disability and Retirement. In the event a Qualifying Event occurs before the
date or dates on which Stock Appreciation Rights vest, the expiration of the
applicable restrictions (other than restrictions based on performance criteria
set forth in Section 14) shall be accelerated and the Participant shall be
entitled to receive the full value of the Stock Appreciation Right free of all
such restrictions. In the case of Stock Appreciation Rights which are based on
performance criteria set forth in Section 14, then as of the date on which such
Qualifying Event occurs, the Participant shall be entitled to receive a value
determined by measuring the selected performance criteria from the Company's
most recent publicly available quarterly results that are available as of the
date the Qualifying Event occurs. All other benefits under the Stock
Appreciation Rights shall thereupon be forfeited and returned to the Company as
of the date on which such Qualifying Event occurs.
(e) Transferability
of Stock Appreciation Rights. Except as otherwise provided in a Participant's
Stock Incentive Agreement, no Stock Appreciation Right granted under the Plan
may be sold, transferred, pledged, assigned or otherwise alienated or
hypothecated, except upon the death of the holder Participant by will or by the
laws of descent and distribution.
(f) Special
Provisions for Tandem Stock Appreciation Rights. A Stock Appreciation Right
granted in connection with an Option may only be exercised to the extent that
the related Option has not been exercised. A Stock Appreciation Right granted in
connection with an ISO (1) will expire no later than the expiration of the
underlying ISO, (2) may be for no more than the difference between the exercise
price of the underlying ISO and the Fair Market Value of the Shares subject to
the underlying ISO at the time the Stock Appreciation Right is exercised, (3)
may be transferable only when, and under the same conditions as, the underlying
ISO is transferable, and (4) may be exercised only (i) when the underlying ISO
could be exercised and (ii) when the Fair Market Value of the Shares subject to
the ISO exceeds the exercise price of the ISO.
SECTION
8.
SECURITIES
REGULATION
8.1 LEGALITY
OF ISSUANCE. No Share shall be issued under this Plan unless and until the
Committee has determined that all required actions have been taken to register
such Share under the Securities Act of 1933 or the Company has determined that
an exemption therefrom is available, any applicable listing requirement of any
stock exchange on which the Share is listed has been satisfied, and any other
applicable provision of state, federal or foreign law, including foreign
securities laws where applicable, has been satisfied.
8.2 RESTRICTIONS
ON TRANSFER; REPRESENTATIONS; LEGENDS. Regardless of whether the offering and
sale of Shares under the Plan have been registered under the Securities Act of
1933 or have been registered or qualified under the securities laws of any
state, the Company may impose restrictions upon the sale, pledge, or other
transfer of such Shares (including the placement of appropriate legends on stock
certificates) if, in the judgment of the Company and its counsel, such
restrictions are necessary or desirable to achieve compliance with the
provisions of the Securities Act of 1933, the securities laws of any state, the
United States or any other applicable foreign law. If the offering and/or sale
of Shares under the Plan is not registered under the Securities Act of 1933 and
the Company determines that the registration requirements of the Securities Act
of 1933 apply but an exemption is available which requires an investment
representation or other representation, the participant shall be required, as a
condition to acquiring such Shares, to represent that such Shares are being
acquired for investment, and not with a view to the sale or distribution
thereof, except in compliance with the Securities Act of 1933, and to make such
other representations as are deemed necessary or appropriate by the Company and
its counsel. All Stock Incentive Agreements shall contain a provision stating
that any restrictions under any applicable securities laws will
apply.
8.3 REGISTRATION
OF SHARES. The Company may, and intends to, but is not obligated to, register or
qualify the offering or sale of Shares under the Securities Act of 1933 or any
other applicable state, federal or foreign law.
SECTION
9.
LIFE OF
PLAN
No
Stock Incentive shall be granted under this Plan on or after the earlier
of:
(a) the
tenth (10th) anniversary of the effective date of this Plan (as determined under
Section 4 of this Plan), or
(b) the
date on which all of the Shares reserved under Section 3 of this Plan have (as a
result of the exercise of Stock Incentives granted under this Plan or lapse of
all restrictions under a Restricted Stock Award or Restricted Stock Unit) been
issued or are no longer available for use under this Plan.
This Plan
shall continue in effect until all outstanding Stock Incentives have been
exercised in full or are no longer exercisable and all Restricted Stock Awards
or Restricted Stock Units have vested or been forfeited.
SECTION
10.
ADJUSTMENT
Notwithstanding
anything in Section 12 to the contrary, (i) the number of Shares reserved under
Section 3 of this Plan, (ii) the limit on the number of Shares that may be
granted subject to Stock Incentives during a calendar year to any individual
under Section 3 of this Plan, (iii) the number of Shares subject to Stock
Incentives granted under this Plan, and (iv) the Exercise Price of any Options
and the specified exercise price of any Stock Appreciation Rights, shall be
adjusted by the Committee in an equitable manner to reflect any change in the
capitalization of the Company, including, but not limited to, such changes as
stock dividends or stock splits. Furthermore, the Committee shall have the right
to adjust (in a manner that satisfies the requirements of Code Section 424(a))
(x) the number of Shares reserved under Section 3, (y) the number of Shares
subject to Stock Incentives granted under this Plan, and (z) the Exercise Price
of any Options and the specified exercise price of any Stock Appreciation Rights
in the event of any corporate transaction described in Code Section 424(a) that
provides for the substitution or assumption of such Stock Incentives. If any
adjustment under this Section creates a fractional Share or a right to acquire a
fractional Share, such fractional Share shall be disregarded, and the number of
Shares reserved under this Plan and the number subject to any Stock Incentives
granted under this Plan shall be the next lower number of Shares, rounding all
fractions downward. An adjustment made under this Section by the Committee shall
be conclusive and binding on all affected persons and, further, shall not
constitute an increase in the number of Shares reserved under Section 3 or an
increase in any limitation imposed by the Plan.
SECTION
11.
CHANGE OF
CONTROL OF THE COMPANY
11.1 GENERAL
RULE FOR CHANGE OF CONTROL. Except as otherwise provided in a Stock Incentive
Agreement, if a Change of Control occurs, and if the agreements effectuating the
Change of Control do not provide for the assumption or substitution of all Stock
Incentives granted under this Plan, with respect to any Stock Incentive granted
under this Plan that is not so assumed or substituted (a "Non Assumed Stock
Incentive"), the Committee, in its sole and absolute discretion, may, with
respect to any or all of such Non Assumed Stock Incentives, take any or all of
the following actions to be effective as of the date of the Change of Control
(or as of any other date fixed by the Committee occurring within the thirty (30)
day period immediately preceding the date of the Change of Control, but only if
such action remains contingent upon the effectuation of the Change of Control)
(such date referred to as the "Action Effective Date"):
(a) Accelerate
the vesting and/or exercisability of such Non Assumed Stock Incentive;
and/or
(b) Unilaterally
cancel such Non Assumed Stock Incentive in exchange for:
(i) whole
and/or fractional Shares (or for whole Shares and cash in lieu of any fractional
Share) or whole and/or fractional shares of a successor (or for whole shares of
a successor and cash in lieu of any fractional share) that, in the aggregate,
are equal in value to the excess of the Fair Market Value of:
(I) in
the case of Options, the Shares that could be purchased subject to such Non
Assumed Stock Incentive less the aggregate Exercise Price for the Options with
respect to such Shares;
(II) in
the case of Restricted Stock Units or Stock Appreciation Rights, Shares subject
to such Stock Incentive determined as of the Action Effective Date (taking into
account vesting), less the value of any consideration payable on
exercise.
(ii) cash
or other property equal in value to the excess of the Fair Market Value
of
(I) in
the case of Options, the Shares that could be purchased subject to such Non
Assumed Stock Incentive less the aggregate Exercise Price for the Options with
respect to such Shares or
(II) in
the case of Restricted Stock Units or Stock Appreciation Rights, Shares subject
to such Stock Incentive determined as of the Action Effective Date (taking into
account vesting) less the value of any consideration payable on
exercise.
(c) In
the case of Options, unilaterally cancel such Non Assumed Option after providing
the holder of such Option with (1) an opportunity to exercise such Non Assumed
Option to the extent vested within a specified period prior to the date of the
Change of Control, and (2) notice of such opportunity to exercise prior to the
commencement of such specified period. However, notwithstanding the foregoing,
to the extent that the recipient of a Non Assumed Stock Incentive is an Insider,
payment of cash in lieu of whole or fractional Shares or shares of a successor
may only be made to the extent that such payment (1) has met the requirements of
an exemption under Rule 16b 3 promulgated under the Exchange Act, or (2) is a
subsequent transaction the terms of which were provided for in a transaction
initially meeting the requirements of an exemption under Rule 16b 3 promulgated
under the Exchange Act. Unless a Stock Incentive Agreement provides otherwise,
the payment of cash in lieu of whole or fractional Shares or in lieu of whole or
fractional shares of a successor shall be considered a subsequent transaction
approved by the original grant of an Option.
11.2 GENERAL
RULE FOR OTHER STOCK INCENTIVE AGREEMENTS. If a Change of Control occurs, then,
except to the extent otherwise provided in the Stock Incentive Agreement
pertaining to a particular Stock Incentive or as otherwise provided in this
Plan, each Stock Incentive shall be governed by applicable law and the documents
effectuating the Change of Control.
SECTION
12.
AMENDMENT
OR TERMINATION
This
Plan may be amended by the Committee from time to time to the extent that the
Committee deems necessary or appropriate; provided, however, no such amendment
shall be made absent the approval of the shareholders of the Company if such
amendment (a) increases the number of Shares reserved under Section 3, except as
set forth in Section 10, (b) extends the maximum life of the Plan under Section
9 or the maximum exercise period under Section 7, (c) decreases the minimum
Exercise Price under Section 7, or (d) changes the designation of Eligible
Recipients eligible for Stock Incentives under Section 6. Shareholder approval
of other material amendments (such as an expansion of the types of awards
available under the Plan, an extension of the term of the Plan, or a change to
the method of determining the Exercise Price of Options issued under the Plan)
may also be required pursuant to rules promulgated by an established stock
exchange or a national market system. An exchange of a later granted Option for
an earlier granted Option for any purpose, including, but not limited to, the
purpose of lowering the Exercise Price of such Option, and an exchange of a
later granted Stock Incentive for an earlier granted Stock Incentive for any
purpose, shall not be deemed to be an amendment to this Plan. The Board also may
suspend the granting of Stock Incentives under this Plan at any time and may
terminate this Plan at any time. The Company shall have the right to modify,
amend or cancel any Stock Incentive after it has been granted if (I) the
modification, amendment or cancellation does not diminish the rights or benefits
of the Stock Incentive recipient under the Stock Incentive (provided, however,
that a modification, amendment or cancellation that results solely in a change
in the tax consequences with respect to a Stock Incentive shall not be deemed as
a diminishment of rights or benefits of such Stock Incentive), (II) the
Participant consents in writing to such modification, amendment or cancellation,
(III) there is a dissolution or liquidation of the Company, (IV) this Plan
and/or the Stock Incentive Agreement expressly provides for such modification,
amendment or cancellation, or (V) the Company would otherwise have the right to
make such modification, amendment or cancellation by applicable
law.
SECTION
13.
MISCELLANEOUS
13.1 SHAREHOLDER
RIGHTS. Except as provided in Section 7.3 with respect to Restricted Stock
Awards, or in a Stock Incentive Agreement, no Participant shall have any rights
as a shareholder of the Company as a result of the grant of a Stock Incentive
pending the actual delivery of Shares subject to such Stock Incentive to such
Participant.
13.2 NO
GUARANTEE OF CONTINUED RELATIONSHIP. The grant of a Stock Incentive to a
Participant under this Plan shall not constitute a contract of employment or
other relationship with the Company and shall not confer on a Participant any
rights upon his or her termination of employment or relationship with the
Company in addition to those rights, if any, expressly set forth in the Stock
Incentive Agreement that evidences his or her Stock Incentive.
13.3 WITHHOLDING.
The Company shall have the power and the right to deduct or withhold, or require
a Participant to remit to the Company as a condition precedent for the grant or
fulfillment of any Stock Incentive, an amount in Shares or cash sufficient to
satisfy federal, state and local taxes, domestic or foreign, required by law or
regulation to be withheld with respect to any taxable event arising as a result
of this Plan and/or any action taken by a Participant with respect to a Stock
Incentive. Whenever Shares are to be issued to a Participant upon exercise of an
Option or Stock Appreciation Right, or satisfaction of conditions under a
Restricted Stock Unit, the Company shall have the right to require the
Participant to remit to the Company, as a condition of exercise of the Option or
Stock Appreciation Right, or as a condition to the fulfillment of the Restricted
Stock Unit, an amount in cash (or, unless the Stock Incentive Agreement provides
otherwise, in Shares) sufficient to satisfy federal, state and local withholding
tax requirements at the time of exercise. However, notwithstanding the
foregoing, to the extent that a Participant is an Insider, satisfaction of
withholding requirements by having the Company withhold Shares may only be made
to the extent that such withholding of Shares (1) has met the requirements of an
exemption under Rule 16b -3 promulgated under the Exchange Act, or (2) is a
subsequent transaction the terms of which were provided for in a transaction
initially meeting the requirements of an exemption under Rule 16b -3 promulgated
under the Exchange Act. Unless the Stock Incentive Agreement provides otherwise,
the withholding of shares to satisfy federal, state and local withholding tax
requirements shall be a subsequent transaction approved by the original grant of
a Stock Incentive. Notwithstanding the foregoing, in no event shall payment of
withholding taxes be made by a retention of Shares by the Company unless the
Company retains only Shares with a Fair Market Value equal to the minimum amount
of taxes required to be withheld.
13.4 NOTIFICATION
OF DISQUALIFYING DISPOSITIONS OF ISO OPTIONS. If a Participant sells or
otherwise disposes of any of the Shares acquired pursuant to an Option that is
an ISO on or before the later of (1) the date two (2) years after the date of
grant of such Option, or (2) the date one (1) year after the exercise of such
Option, then the Participant shall immediately notify the Company in writing of
such sale or disposition and shall cooperate with the Company in providing
sufficient information to the Company for the Company to properly report such
sale or disposition to the Internal Revenue Service. The Participant
acknowledges and agrees that he or she may be subject to federal, state and/or
local tax withholding by the Company on the compensation income recognized by
Participant from any such early disposition, and agrees that he or she shall
include the compensation from such early disposition in his gross income for
federal tax purposes. Participant also acknowledges that the Company may
condition the exercise of any Option that is an ISO on the Participant's express
written agreement with these provisions of this Plan.
13.5 TRANSFERS
& RESTRUCTURINGS. The transfer of a Participant's employment between or
among the Company or a Subsidiary (including the merger of a Subsidiary into the
Company) shall not be treated as a termination of his or her employment under
this Plan. Likewise, the continuation of employment by a Participant with a
corporation which is a Subsidiary shall be deemed to be a termination of
employment when such corporation ceases to be a Subsidiary.
13.6 GOVERNING
LAW/CONSENT TO JURISDICTION. This Plan shall be construed under the laws of the
State of Colorado without regard to principles of conflicts of law. Each
Participant consents to the exclusive jurisdiction in the United States District
Court for the District of Colorado, or the state courts in Denver, Colorado for
the determination of all disputes arising from this Plan and waives any rights
to remove or transfer the case to another court.
13.7 ESCROW
OF SHARES. To facilitate the Company's rights and obligations under this Plan,
the Company reserves the right to appoint an escrow agent, who shall hold the
Shares owned by a Participant pursuant to this Plan.
SECTION
14.
PERFORMANCE
CRITERIA
14.1 PERFORMANCE
GOAL BUSINESS CRITERIA. Unless and until the Board proposes for shareholder vote
and shareholders approve a change in the general performance measures set forth
in this Section, the attainment of which may determine the degree of payout
and/or vesting with respect to Stock Incentives to Key Employees and Key Persons
pursuant to this Plan which are designed to qualify for the Performance Based
Exception, the performance measure(s) to be used by the Committee for purposes
of such grants shall be determined by the Committee in its discretion. These
performance measure may include but are not limited to the following: (a)
earnings per share; (b) net income (before or after taxes); (c) return measures
(including, but not limited to, return on assets, equity or sales); (d) cash
flow return on investments which equals net cash flows divided by owners equity;
(e) earnings before or after taxes, depreciation and/or amortization; (f) gross
revenues; (g) operating income (before or after taxes); (h) total shareholder
return; (i) corporate performance indicators (indices based on the level of
certain services provided to customers); (j) cash generation, profit and/or
revenue targets; (k) growth measures, including revenue growth, as compared with
a peer group or other benchmark; (l) share price (including, but not limited to,
growth measures and total shareholder return), and/or (m) any other measures
deemed appropriate by the Committee. In setting performance goals using these
performance measures, the Committee may exclude the effect of changes in
accounting standards and non recurring unusual events specified by the
Committee, such as write offs, capital gains and losses and acquisitions and
dispositions of businesses.
14.2 DISCRETION
IN FORMULATION OF PERFORMANCE GOALS. The Committee shall have the discretion to
adjust the determinations of the degree of attainment of the pre established
performance goals; provided, however, that Stock Incentives which are to qualify
for the Performance Based Exception may not be adjusted upward (although the
Committee shall retain the discretion to adjust such Stock Incentives
downward).
14.3 PERFORMANCE
PERIODS. The Committee shall have the discretion to determine the period during
which any performance goal must be attained with respect to a Stock Incentive.
Such period may be of any length, and must be established prior to the start of
such period or within the first ninety (90) days of such period (provided that
the performance criteria are not in any event set after 25% or more of such
period has elapsed).
14.4 MODIFICATIONS
TO PERFORMANCE GOAL CRITERIA. In the event that the applicable tax and/or
securities laws and regulatory rules and regulations change to permit Committee
discretion to alter the governing performance measures noted above without
obtaining shareholder approval of such changes, the Committee shall have sole
discretion to make such changes without obtaining shareholder approval. In
addition, in the event that the Committee determines that it is advisable to
grant Stock Incentives which shall not qualify for the Performance Based
Exception, the Committee may make such grants without satisfying the
requirements under Code Section 162(m) to qualify for the Performance Based
Exception.
14.5 ACHIEVEMENT
OF PERFORMANCE GOALS. The Committee shall have the discretion to determine
whether or not a certain performance goal has been attained and the Committee
may delegate this authority to management in those cases where it elects to do
so.
SECTION
15.
OTHER NON
US PROVISIONS
15.1 The
Committee shall have the authority to require that any Stock Incentive Agreement
relating to a Stock Incentive in a jurisdiction outside of the United States
contain such terms as are required by local law in order to constitute a valid
grant under the laws of such jurisdiction. Such authority shall be
notwithstanding the fact that the requirements of the local jurisdiction may be
different from or more restrictive than the terms set forth in this Plan. No
purchase or delivery of Shares pursuant to a Stock Incentive shall occur until
applicable restrictions imposed pursuant to this Plan or the applicable Stock
Incentive have terminated.
To
record the adoption of this Plan, by the Board, the Company has caused its
authorized officer to execute the same.
MusclePharm
Corporation
By:_________________________________
Name:_______________________________
Title:______________________________
Date:_________________